PMN ProMIS Neurosciences Inc.
Price Chart
Executive Summary
ProMIS Neurosciences' S-3 shelf registration has become effective, allowing the company to raise up to $200 million through various securities, including a $50 million ATM offering. This creates a potential for near-term dilution, especially given the company's $112 million market cap and recent history of share issuances. The effectiveness follows two prior S-3 filings within the last 16 days, signaling aggressive capital-raising activity.
Actionable Insight
Traders should monitor for imminent share issuance, particularly under the $50 million ATM program, which could pressure the stock price. The repeated shelf filings in quick succession suggest urgent funding needs, increasing the likelihood of near-term dilution. Consider hedging or reducing exposure ahead of expected offerings.
Key Facts
- S-3 shelf registration (File No. 333-294610) became effective on 2026-04-02
- Registration allows ProMIS to raise up to $200 million through debt, equity, or hybrid securities
- Includes a $50 million ATM offering facility with H.C. Wainwright
- Company market cap is $112 million, meaning even modest offerings represent significant dilution
- This is the third S-3-related filing in 16 days, indicating urgent capital needs
Financial Impact
Up to $200 million in potential dilution; $50 million ATM offering alone would increase shares outstanding by over 44% at current market cap
Risk Factors
- Significant share dilution from ATM or other offerings under the shelf
- Downward pressure on stock price due to oversupply of shares
- Potential for insider selling coinciding with new issuance
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001071 |
| Document: 9999999995-26-001071-index.html | 9999999995-26-001071 |
| Document: 9999999995-26-001071.txt | 9999999995-26-001071 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
12d ago
|
Press Release
| $10.87 $9.65 | ▼ −11.22% | ▼ −11.18% | $9.74 (−10.35%) |
|
May 12, 2026
28d ago
|
8-K
| $10.49 $10.44 | ▼ −0.48% | ▼ −0.55% | $9.74 (−7.10%) |
|
Apr 3, 2026
9w ago
|
EFFECT
| $10.96 $12.92 | ▼ −17.88% | ▼ −13.75% | $9.74 (+11.09%) |
|
Mar 25, 2026
10w ago
|
S-3
| $15.13 $12.51 | ▲ +17.32% | ▲ +18.95% | $9.74 (+35.59%) |
|
Mar 18, 2026
11w ago
|
S-3
| $18.21 $15.13 | ▲ +16.91% | ▲ +14.70% | $9.74 (+46.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access